PureTech Health plc (LON:PRTC - Get Free Report) shares traded down 15.2% on Tuesday . The company traded as low as GBX 117.20 ($1.53) and last traded at GBX 117.20 ($1.53). 42,764,352 shares changed hands during trading, an increase of 2,645% from the average session volume of 1,557,904 shares. The stock had previously closed at GBX 138.20 ($1.81).
Analyst Ratings Changes
Separately, Jefferies Financial Group reiterated a "buy" rating and set a GBX 455 ($5.95) price target on shares of PureTech Health in a research note on Monday, December 16th.
View Our Latest Stock Report on PureTech Health
PureTech Health Stock Performance
The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.68. The firm has a market capitalization of £354.45 million, a PE ratio of -4.84 and a beta of 1.02. The business's fifty day simple moving average is GBX 135.24 and its 200-day simple moving average is GBX 148.09.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
See Also
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
